PNV 2.35% $2.61 polynovo limited

“the team are currently refining the grown of the composite skin...

  1. 1,826 Posts.
    lightbulb Created with Sketch. 365

    “the team are currently refining the grown of the composite skin of the dermis and epidermis, making it more reliable and effective. Their aim is to start clinical trials within approximately 18 months”

    So that would be by the end of calendar 2023 or beginning of 2024. Excellent news.


 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.